ROLE OF NOVEL ORAL ANTICOAGULANTS (NOACS)IN PATIENTS WITH ATRIAL FIBRILLATION CARDIOVERSION- AN EXECUTIVE SUMMARY
Journal: International Journal of Advanced Research (Vol.9, No. 02)Publication Date: 2021-02-16
Authors : Wang Jing; Phav Sophearith;
Page : 853-861
Keywords : Atrial Fibrillation Cardioversion Rivaroxaban Warfarin NOAC Stroke Systemic Embolism Diabetes Mellitus Coronary Artery Disease;
Abstract
In patients with non-valvular atrial fibrillation (NVAF), oral anticoagulation is necessary for prevention of stroke and systemic embolism especially during cardioversion. While Vitamin K antagonists (VKAs) have historically been the standard of care, these medications are limited by numerous food and drug interactions with requirements for frequent monitoring (INR) and dose adjustments. Over the past decade, several novel oral anticoagulants (NOACs) have been developed to directly inhibit factor IIa/thrombin (dabigatran) or activated factor X (apixaban, rivaroxaban, edoxaban). These medications have been shown to be at least as effective as warfarin for stroke prevention in NVAF with more favorable safety profiles. However, their advantages are underscored by a lack of specific antidotes and assays quantifying their anticoagulant effects. This review addresses how well do the Rivaroxaban prevents stroke and systemic embolism compare to VKAs in patients with NVAF, with a special focus on high-risk populations, including the elderly, those with renal disease, diabetes mellitus, coronary artery disease, and previous stroke.
Other Latest Articles
- LARGE BENIGN OVARIAN TUMOR MIMICKING LATE STAGE MALIGNANT OVARIAN TUMOR
- Comparative Study Of The Germination Power And Growth In The Nursery Of Two Varieties Of Oil Palm In Grand-Lahou (Cote d,Ivoire)
- Influence of soil pH and microbes on mineral solubility and plant nutrition: A Review
- Evaluating of Salinity Tolerance and Aroma of Rice Lines at BC3F5 Generation in the Mekong Delta, Vietnam
- Effect of Operating Speed and Chipping Disc Blade Number on the Performance of a Motorised Cassava Chipping Machine
Last modified: 2021-03-31 18:38:36